Todd Foley, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 58,600 shares at $20.19 ($1.2M) on 2020-05-28, disclosed to the SEC on 2020-05-28.
Open-market sale of $1.2M RYTM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.13 | 10,148 | $204K | 17.3% |
| 2 | $20.13 | 10,148 | $204K | 17.3% |
| 3 | $20.19 | 19,152 | $387K | 32.7% |
| 4 | $20.19 | 19,152 | $387K | 32.7% |
| Total | $20.17 avg | 58,600 | $1.2M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |